Peritonitis and technique failure caused by Roseomonas mucosa in an adolescent infected with HIV on continuous cycling peritoneal dialysis

Journal of Clinical Microbiology

Volumn 50, Issue 11, 2012, Pages 3801-3804

  Boyd, Mary Adetinuke ^a   Laurens, Matthew B ^a,b   Fiorella, Paul D ^c   Mendley, Susan R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

^c Retrovirology Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; AMIKACIN; ATAZANAVIR; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LAMIVUDINE; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; RITONAVIR; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL PERITONITIS; BACTERIUM IDENTIFICATION; CASE REPORT; CATHETER REMOVAL; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CULTURE MEDIUM; DIALYSATE; FEVER; FOCAL GLOMERULOSCLEROSIS; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; LEUKOCYTE COUNT; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL COUNT; NUCLEOTIDE SEQUENCE; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; RECURRENT DISEASE; ROSEOMONAS MUCOSA; SCAR FORMATION; STREPTOCOCCUS AGALACTIAE; TREATMENT FAILURE; VIRUS LOAD;

ADOLESCENT; BACTERIAL TYPING TECHNIQUES; CLUSTER ANALYSIS; CROSS INFECTION; DNA, BACTERIAL; DNA, RIBOSOMAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HIV INFECTIONS; HUMANS; METHYLOBACTERIACEAE; PERITONEAL DIALYSIS; PERITONITIS; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84867522560     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01437-12     Document Type: Article

References (27)

1. Bard JD, Deville JG, Summanen PH, Lewinski MA. 2010. Roseomonas mucosa isolated from bloodstream of pediatric patient. J. Clin. Microbiol. 48:3027-3029.
2. Bibashi E, Sofianou D, Kontopoulou K, Mitsopoulos E, Kokolina E. 2000. Peritonitis due to Roseomonas fauriae in a patient undergoing continuous ambulatory peritoneal dialysis. J. Clin. Microbiol. 38:456-457. (Pubitemid 30043343)
3. Chadha V, Schaefer FS, Warady BA. 2010. Dialysis-associated peritonitis in children. Pediatr. Nephrol. 25:425-440.
4. Christakis GB, Perlorentzou S, Alexaki P, Megalakaki A, Zarkadis IK. 2006. Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece. J. Med. Microbiol. 55:1153-1156. (Pubitemid 44215576)
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Dé I, Rolston KV, Han XY. 2004. Clinical significance of Roseomonas species isolated from catheter and blood samples: analysis of 36 cases in patients with cancer. Clin. Infect. Dis. 38:1579-1584. (Pubitemid 38738554)
7. Elshibly S, et al. 2005. Central line-related bacteremia due to Roseomonas mucosa in a patient with diffuse large B-cell non-Hodgkin's lymphoma. Leuk. Lymphoma 46:611-614. (Pubitemid 40584880)
8. Fahim M, et al. 2010. Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am. J. Kidney Dis. 55:690-697.
9. Fanella S, Schantz D, Karlowsky J, Rubinstein E. 2009. Septic arthritis due to Roseomonas gilardii in an immunocompetent adolescent. J. Med. Microbiol. 58:1514-1516.
10. Han XY, et al. 2003. Bacteriologic characterization of 36 strains of Roseomonas species and proposal of Roseomonas mucosa sp nov and Roseomonas gilardii subsp rosea subsp nov. Am. J. Clin. Pathol. 120:256-264. (Pubitemid 37046360)
11. Kan GW, Thomas MA, Heath CH. 2003. A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: is empiric vancomycin still indicated for some patients? Perit. Dial. Int. 23:465-468. (Pubitemid 37321751)
12. Lewis L, Stock F, Williams D, Weir S, Gill VJ. 1997. Infections with Roseomonas gilardii and review of characteristics used for biochemical identification and molecular typing. Am. J. Clin. Pathol. 108:210-216. (Pubitemid 27328295)
13. Li PK, et al. 2010. Peritoneal dialysis-related infections recommendations: 2010 update. Perit. Dial. Int. 30:393-423. (Erratum, 31:512, 2011).
14. Mandell GL, Bennett JE, Dolin R. 2010. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Churchill Livingstone/Elsevier, Philadelphia, PA.
15. Najafi I, et al. 2011. Epidemiology of culture-negative peritonitis in Iranian patients on continuous ambulatory peritoneal dialysis. Iran. J. Kidney Dis. 5:332-337.
16. Rihs JD, et al. 1993. Roseomonas, a new genus associated with bacteremia and other human infections. J. Clin. Microbiol. 31:3275-3283. (Pubitemid 23335622)
17. Sandoe JA, Malnick H, Loudon KW. 1997. A case of peritonitis caused by Roseomonas gilardii in a patient undergoing continuous ambulatory peritoneal dialysis. J. Clin. Microbiol. 35:2150-2152. (Pubitemid 27318724)
18. Sipsas NV, et al. 2006. Septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy. Diagn. Microbiol. Infect. Dis. 55:343-345. (Pubitemid 44128725)
19. Siva B, et al. 2009. Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases. Clin. J. Am. Soc. Nephrol. 4:957-964.
20. Struthers M, Wong J, Janda JM. 1996. An initial appraisal of the clinical significance of Roseomonas species associated with human infections. Clin. Infect. Dis. 23:729-733. (Pubitemid 26331115)
21. Subudhi CP, Adedeji A, Kaufmann ME, Lucas GS, Kerr JR. 2001. Fatal Roseomonas gilardii bacteremia in a patient with refractory blast crisis of chronic myeloid leukemia. Clin. Microbiol. Infect. 7:573-575. (Pubitemid 34960353)
22. Szeto C, et al. 2005. The clinical course of peritoneal dialysis-related peritonitis caused by Corynebacterium species. Nephrol. Dial. Transplant. 20:2793-2796. (Pubitemid 41672281)
23. Toro C, et al. 2000. Isolation of Roseomonas gilardii in a patient with AIDS. Enferm. Infecc. Microbiol. Clin. 18:250-251. (Pubitemid 32120767)
24. Wallace PL, Hollis DG, Weaver RE, Moss CW. 1990. Biochemical and chemical characterization of pink-pigmented oxidative bacteria. J. Clin. Microbiol. 28:689-693. (Pubitemid 20123820)
25. Wang CM, et al. 2012. Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates. Diagn. Microbiol. Infect. Dis. 72:199-203.
26. Woodrow G, Turney JH, Brownjohn AM. 1997. Technique failure in peritoneal dialysis and its impact on patient survival. Perit. Dial. Int. 17:360-364. (Pubitemid 27470211)
27. Zelenitsky S, et al. 2000. Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am. J. Kidney Dis. 36:1009-1013.